Navigation Links
Novartis Class Awarded $250 Million in Punitive Damages
Date:5/19/2010

NEW YORK, May 19 /PRNewswire/ -- After delivering a unanimous verdict against Novartis on all counts and awarding 12 former Novartis sales reps $3.36 million in compensatory damages yesterday, a New York jury today delivered a stronger dose of the same medicine.  Announcing the amount of punitive damages to be awarded, the jury determined that Novartis must pay an additional $250 million for the gender discrimination it inflicted on 5,600 working women in the class. The case was the largest gender discrimination matter ever to go to verdict in the U.S.

Monday's sweeping verdict found Novartis liable for gender discrimination in pay, promotional opportunities and pregnancy-related matters. Today's punitive damage award is meant to punish the company for its past actions and to deter it and others from continuing to discriminate against female employees in the future.

The announcement of punitive damages came after Judge McMahon instructed jurors to consider the amount of punitive damages award in light of the offensiveness of Novartis' behavior, the nature and extent of the harm done, the length of time the class endured the behavior, the extent to which Novartis knew about the discrimination and how they reacted once they were on notice and the amount needed to deter repetition of Novartis' conduct in light of Novartis' financial condition.

The women were represented in the matter by David Sanford, Steven Wittels and Katherine Kimpel in the New York and Washington, D.C. offices of Sanford, Wittels & Heisler LLP, and

SOURCE Sanford Wittels & Heisler LLP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
2. Oral Drug From Novartis/Mitsubishi Tanabe Will Capture the Largest Market Share of All Emerging Multiple Sclerosis Therapies in 2017
3. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
4. Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
5. Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
6. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
7. Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US
8. Novartis/Schering-Ploughs Drug Will Replace AstraZenecas Symbicort as Decision Resources Clinical Gold Standard by 2012 for the Treatment of Asthma
9. Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD
10. Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure
11. Heptares Therapeutics Announces Agreement With Novartis Option Fund to Apply its StaR(TM) Technology and Generate Novel Drug Leads Against a GPCR Target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... York (PRWEB) December 23, 2014 According to ... Long Island Affiliate of ITRA Global, the national office market ... steady recovery. This is evidenced by the third quarter’s ... stock market. Low energy costs have held inflation down ... only negative is the housing market remaining soft. , This ...
(Date:12/24/2014)... The report expects global cell isolation and expansion ... provides a carefully analyzed data about the vital drivers, ... , Full Copy of Report @ http://bit.ly/1yUxy0T ... cell expansion will keep witnessing growth at an impressive ... be driven by rapid technological advancements, government funding and ...
(Date:12/24/2014)... 2014 Vermillion, Inc. (Nasdaq:   VRML), ... announced today that investors including Oracle Investment Management, ... and several Vermillion directors have agreed to purchase ... common stock and warrants to purchase unregistered shares ... Under the terms of the ...
(Date:12/24/2014)... SARASOTA, Fla. , Dec. 23, 2014  Rock ... today that it has filed a Clinical Trial Application ... Medicines Healthcare products Regulatory Agency (MHRA) seeking regulatory approval ... its lead molecule, Anatabine Citrate. Contingent on ... to conduct a Phase I trial to assess the ...
Breaking Biology Technology:ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... A blend of mobile, electronic learning techniques could be the ... technology for the University of Wisconsin-Madison and director of the ... chapter of the World Future Society last Thursday night ... hardware and culture, Brown talked about where developers are succeeding ...
... dont always have to help people in a significant way ... sale). In reality, people also appreciate little acts of kindness ... paying for meals). , ,While these details may seem trivial ... you and your networking style. Pay attention to how you ...
... earnings may be the least of the news coming ... Milwaukee-based maker of radiology information system (RIS) and picture ... reported record fiscal results this week for the quarter ... of new strategic partnerships and its growing international business. ...
Cached Biology Technology:Technology puts pressure on old education methods 2Little things can be big in networking 2Little things can be big in networking 3Balance-sheet success leads to hunt for market dominance at Merge 2Balance-sheet success leads to hunt for market dominance at Merge 3
(Date:12/22/2014)... , Dec. 22, 2014 Research and ... announced the addition of the "The ... to their offering. ... provides an overview of the global digital ... to control and monitor piracy by securely ...
(Date:12/19/2014)... VIEW, Calif. , Dec. 18, 2014  23andMe, ... publication of a study that pinpoints fine-scale differences in ... United States . Since immigrants first ... the United States has served as a ... illuminates how American history and the ongoing mixing of ...
(Date:12/17/2014)... NEW YORK , Dec. 15, 2014 /PRNewswire-USNewswire/ ... a Good Clinical Practices (GCP) audit to confirm ... Administration (FDA) regulations. This accomplishment enables HITLAB to ... trials utilizing the highest principles for patient safety ... to improve global healthcare access, quality, and delivery ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... usually the preserve of Hollywood blockbusters. But when it ... real life. As controversy about research into the H5N1 ... a complete overhaul of current approaches to pandemic preparedness. ... Influenza, by Dr Paul Forster, of the ESRC STEPS ...
... Shenzhen, China (28 January 2013) In a scientific ... drought tolerance and disease resistance, and enhanced genetic diversity, ... not one but ninety genomes of chickpea. , ... area of biotechnology, featured the reference genome of the ...
... GRAFTON, Mass. (January 28, 2013)A popular dog treat could ... possibly be contaminated by bacteria, according to a study ... of Veterinary Medicine at Tufts University and the University ... or "pizzle stick." The American and Canadian researchers analyzed ...
Cached Biology News:Pandemic controversies: The global response to pandemic influenza must change 2Global research team decodes genome sequence of 90 chickpea lines 2Global research team decodes genome sequence of 90 chickpea lines 3Misconceptions about a popular pet treat 2Misconceptions about a popular pet treat 3
...
...
... High Resolution - Efficiently ... 50 to 1000 bp. ... sizing PCR fragments, small ... restriction enzyme digestion, and ...
... MW 140kDa GenBank Accession ... spanning amino acids 926-941 (DKKVKPPFIPTIRGRE) of human ... Quality Assurance Routinely evaluated ... cells. Stability 1 year ...
Biology Products: